文献速递消化道肿瘤放疗胸部肿瘤放疗

食管癌幸存者新辅助放化疗的晚期心脏毒性:一项前瞻性横断面先导研究

Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study.
PubMed 文献 · Radiother Oncol · 2021-12-02

该前瞻性横断面先导研究纳入食管癌根治性切除术后随访5-15年的幸存者,比较接受新辅助放化疗(n=20)与仅手术(n=20)者的亚临床心脏毒性。nCRT组心肌纤维化(平均细胞外容积28.4 vs 24.0,p<0.01)和角色功能评分(95.0 vs 88.8,p=0.03)差异有统计学意义,房颤和传导改变发生率数值较高但未达统计学显著。作者假设放射性心肌纤维化在心脏毒性中起核心作用,并强调需在更大队列中验证。

要点

  • nCRT组平均细胞外容积28.4 vs 仅手术组24.0,p<0.01,提示心肌纤维化增加。
  • nCRT组角色功能评分95.0 vs 仅手术组88.8,p=0.03,提示生活质量受影响。
  • 线性晚期钆增强4 vs 1(p=0.13)和房颤6 vs 2(p=0.07)未达统计学显著。

核心结论

  • 作者假设在食管癌患者中,放射性心肌纤维化在心脏毒性中起核心作用,导致房颤、传导改变并最终降低角色功能。
  • 作者强调需要在更大患者队列中验证这些发现。

研究设计与样本

  • 前瞻性横断面先导研究,纳入食管癌根治性切除术后随访5-15年的幸存者,接受nCRT者20例、仅手术者20例。
  • 所有患者接受心脏CT和MRI、超声心动图、心电图、6分钟步行试验、体格检查和EORTC问卷等临床与诊断检查。

主要发现

  • nCRT组 vs 仅手术组:线性晚期钆增强4 vs 1(p=0.13),平均细胞外容积28.4 vs 24.0(p<0.01)。
  • nCRT组 vs 仅手术组:房颤6 vs 2(p=0.07)。
  • nCRT组 vs 仅手术组:心电图传导改变发生率增加。
  • nCRT组 vs 仅手术组:角色功能评分95.0 vs 88.8(p=0.03),nCRT组更差。

局限性

  • 原文结论指出需要在更大患者队列中验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although cure rates in esophageal cancer (EC) have improved since the introduction of neoadjuvant chemoradiation (nCRT), evidence for treatment-related cardiac toxicity is growing, of which the exact mechanisms remain unknown. The primary objective of this study was to identify (subclinical) cardiac dysfunction in EC patients after nCRT followed by surgical resection as compared to surgery alone. MATERIALS AND METHODS: EC survivors followed for 5-15 years after curative resection with (n = 20) or without (n = 20) nCRT were enrolled in this prospective cross-sectional pilot study. All patients underwent several clinical and diagnostic tests in order to objectify (sub)clinical cardiac toxicity including cardiac CT and MRI, echocardiography, ECG, 6-minutes walking test, physical examination and EORTC questionnaires. RESULTS: We found an increased rate of myocardial fibrosis (Linear late gadolinium enhancement (LGE) 4 vs. 1; p = 0.13; mean extracellular volume (ECV) 28.4 vs. 24.0; p < 0.01), atrial fibrillation (AF) (6 vs. 2; p = 0.07) and conduction changes in ECG among patients treated with nCRT as compared to those treated with surgery alone. The results suggested an impact on quality of life in terms of worse role functioning for this patient group (95.0 vs. 88.8; p = 0.03). CONCLUSION: Based on our analyses we hypothesize that in EC patients, radiation-induced myocardial fibrosis plays a central role in cardiac toxicity leading to AF, conduction changes and ultimately to decreased role functioning. The results emphasize the need to verify these findings in larger cohorts of patients.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Beukema JC, de Groot C, Plukker JTM, et al. Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study. Radiother Oncol. 2021. PMID: 34864136. doi:10.1016/j.radonc.2021.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。